In a time of increasingly bespoke healthcare, Elizabeth Philp has established herself as a formidable force of innovation, notably in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a push to make bespoke medications more available, questioning the traditional one-